Harnessing the cell death pathway for targeted cancer treatment.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 21969218PMCID PMC3180107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors.

  2010cited by this paper
• A Phase I Trial of Oblimersen Sodium in Combination With Cisplatin and 5-Fluorouracil in Patients With Advanced Esophageal, Gastroesophageal Junction, and Gastric Carcinoma

  2010cited by this paper
• The Role of the Kinases RIP1 and RIP3 in TNF-Induced Necrosis

  2010cited by this paper
• TRAILing death in cancer.

  2010cited by this paper
• Positive selection on apoptosis related genes

  2010cited by this paper
• Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy.

  2010cited by this paper
• Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom macroglobulinemia.

  2010cited by this paper
• Prognostic and predictive value of p53 in low MGMT expressing glioblastoma treated with surgery, radiation and adjuvant temozolomide chemotherapy

  2010influential reference
• Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer.

  2010cited by this paper
• Geldanamycin and its anti-cancer activities.

  2010cited by this paper
• Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer

  2010cited by this paper
• Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508

  2010cited by this paper
• ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin-DNA adducts.

  2010cited by this paper
• Small-Molecule XIAP Inhibitors Enhance γ-Irradiation-Induced Apoptosis in Glioblastoma

  2009cited by this paper
• Sunitinib Prolongs Survival in Genetically Engineered Mouse Models of Multistep Lung Carcinogenesis

  2009cited by this paper
• Elevated Poly-(ADP-Ribose)-Polymerase Activity Sensitizes Retinoblastoma-Deficient Cells to DNA Damage–Induced Necrosis

  2009influential reference
• A Six-Nucleotide Insertion-Deletion Polymorphism in the CASP8 Promoter Associated with Risk and Progression of Bladder Cancer

  2009cited by this paper
• Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia.

  2009cited by this paper
• An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer

  2009cited by this paper
• Translation of the radio- and chemo-inducible TNFerade vector to the treatment of human cancers

  2009cited by this paper
• Phase I study of apoptosis gene modulation with oblimersen within preoperative chemotherapy in patients with primary breast cancer.

  2009cited by this paper
• Regulation of Beclin 1 in autophagy

  2009cited by this paper
• Detection of CpG island hypermethylation of caspase‐8 in neuroblastoma using an oligonucleotide array

  2009cited by this paper
• Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts.

  2009cited by this paper
• Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myeloma

  2009cited by this paper
• Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome C as proapoptotic protein.

  2009influential reference
• Human melanoma cells under endoplasmic reticulum stress are more susceptible to apoptosis induced by the BH3 mimetic obatoclax.

  2009cited by this paper
• Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer.

  2009cited by this paper
• Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia.

  2009cited by this paper
• RIP kinases initiate programmed necrosis.

  2009cited by this paper
• Autophagic cell death.

  2009cited by this paper
• Small-molecule XIAP inhibitors enhance gamma-irradiation-induced apoptosis in glioblastoma.

  2009cited by this paper
• A phase II study of cisplatin and temozolomide in heavily pre-treated patients with temozolomide-refractory high-grade malignant glioma.

  2009cited by this paper
• Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).

  2009cited by this paper
• A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB

  2009cited by this paper
• Autophagy in disease: a double-edged sword with therapeutic potential.

  2009influential reference
• Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions

  2009cited by this paper
• Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer

  2009cited by this paper
• Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic study.

  2009cited by this paper
• Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

  2009cited by this paper
• G3139 (Genasense) in Patients With Advanced Merkel Cell Carcinoma

  2009cited by this paper
• Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.

  2009cited by this paper
• Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study

  2009cited by this paper
• Targeting HSP70 for cancer therapy.

  2009cited by this paper
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

  2009influential reference
• Mechanisms of amino acid sensing in mTOR signaling pathway

  2009cited by this paper
• Decreased expression of Bax‐interacting factor‐1 (Bif‐1) in invasive urinary bladder and gallbladder cancers

  2008cited by this paper
• TRAIL Resistance of Breast Cancer Cells Is Associated with Constitutive Endocytosis of Death Receptors 4 and 5

  2008cited by this paper
• A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies

  2008cited by this paper
• Phase II multicenter study of oblimersen sodium, a Bcl‐2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B‐cell non‐Hodgkin lymphoma

  2008cited by this paper
• Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.

  2008cited by this paper
• Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells.

  2008cited by this paper
• Regulation of autophagy by cytoplasmic p53

  2008cited by this paper
• Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability.

  2008cited by this paper
• CD133-positive cells are resistant to TRAIL due to up-regulation of FLIP.

  2008cited by this paper
• Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer

  2008cited by this paper
• JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy.

  2008cited by this paper
• Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer.

  2008cited by this paper
• Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma.

  2008cited by this paper
• Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells

  2008cited by this paper
• Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.

  2008cited by this paper
• Acquired resistance to Fas/CD95 ligation in U937 cells is associated with multiple molecular mechanisms.

  2008cited by this paper
• The selectivity of autophagy and its role in cell death and survival

  2008influential reference
• RIP1, a kinase on the crossroads of a cell's decision to live or die

  2007cited by this paper
• Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study.

  2007cited by this paper
• Haploinsufficiency of Parp1 accelerates Brca1-associated centrosome amplification, telomere shortening, genetic instability, apoptosis, and embryonic lethality

  2007cited by this paper
• Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.

  2007cited by this paper
• Prevalence and specificity of LKB1 genetic alterations in lung cancers

  2007cited by this paper
• Phase 1 and Pharmacokinetic Study of Lexatumumab in Patients with Advanced Cancers

  2007cited by this paper
• Self-eating and self-killing: crosstalk between autophagy and apoptosis

  2007cited by this paper
• Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1.

  2007cited by this paper
• Cytokeratin-18 Is a Useful Serum Biomarker for Early Determination of Response of Breast Carcinomas to Chemotherapy

  2007cited by this paper
• Self-eating and self-killing: crosstalk between autophagy and apoptosis.

  2007cited by this paper
• Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells

  2007cited by this paper
• Functional and physical interaction between Bcl‐XL and a BH3‐like domain in Beclin‐1

  2007influential reference
• CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme.

  2007cited by this paper
• Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1.

  2007cited by this paper
• Decreased expression of tumour suppressor Bax‐interacting factor‐1 (Bif‐1), a Bax activator, in gastric carcinomas

  2006cited by this paper
• Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas

  2006cited by this paper
• Bcl-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated with Taxane-Based Chemotherapy

  2006cited by this paper
• Poly(ADP-ribose) Polymerase-1 Signaling to Mitochondria in Necrotic Cell Death Requires RIP1/TRAF2-mediated JNK1 Activation*

  2006cited by this paper
• Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.

  2006cited by this paper
• Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma

  2006cited by this paper
• Chemotherapeutic approaches for targeting cell death pathways.

  2006cited by this paper
• The Problem of Cancer Dormancy: Understanding the Basic Mechanisms and Identifying Therapeutic Opportunities

  2006cited by this paper
• Opposing Roles of Mitogenic and Stress Signaling Pathways in the Induction of Cancer Dormancy

  2006cited by this paper
• Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma.

  2006cited by this paper
• MGMT gene silencing and benefit from temozolomide in glioblastoma.

  2005cited by this paper
• Role of JNK activation in apoptosis: A double-edged sword

  2005cited by this paper
• Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis

  2005cited by this paper
• Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients.

  2005cited by this paper
• Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy.

  2005influential reference
• Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors.

  2005cited by this paper
• Early results of a phase I trial of oblimersen sodium for relapsed or refractory Waldenstrom's macroglobulinemia.

  2005cited by this paper
• Regulation of the Expression of Caspase-9 by the Transcription Factor Activator Protein-4 in Glucocorticoid-induced Apoptosis*

  2005cited by this paper
• Growth factor regulation of autophagy and cell survival in the absence of apoptosis.

  2005cited by this paper
• Regulation of an ATG7-beclin 1 Program of Autophagic Cell Death by Caspase-8

  2004cited by this paper
• Autophagy and Caspases: A New Cell Death Program

  2004cited by this paper
• Cell Cycle Checkpoint Proteins and Cellular Response to Treatment by Anticancer Agents

  2004cited by this paper
• Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker.

  2004cited by this paper

• Multi-targeted immunotherapeutics to treat B cell malignancies.

  2023cites this paper
• Exploring the Potential of Thymoquinone-Stabilized Selenium Nanoparticles: In HEC1B Endometrial Cancer Cells Revealing Enhanced Anticancer Efficacy

  2023cites this paper
• The mosaic puzzle of the therapeutic monoclonal antibodies and antibody fragments - A modular transition from full-length immunoglobulins to antibody mimetics

  2022cites this paper
• Apatinib induced ferroptosis by lipid peroxidation in gastric cancer

  2021cites this paper
• Detection of Cell Death Mechanisms: Methods and Protocols

  2021cites this paper
• The Effect of Brazilin from Caesalpinia sappan on Cell Cycle and Modulation and Cell Senescence in T47D cells

  2020influential citation
• The Phylum Bryozoa: From Biology to Biomedical Potential

  2020cites this paper
• Determining Cell Death Pathway and Regulation by Enrichment Analysis.

  2020cites this paper
• Hydrogen sulfide inhibits apoptosis and protects the bronchial epithelium in an allergic inflammation mice model.

  2019cites this paper
• Influence of copper (I) nicotinate complex and autophagy modulation on doxorubicin-induced cytotoxicity in HCC1806 breast cancer cells.

  2019cites this paper
• Design and Production of Bispecific Antibodies

  2019cites this paper
• Vitamin D3–assisted chemo-photodynamic therapy of rhabdomyosarcoma cancer cells for effective treatment

  2018cites this paper
• Role of Surface Hydrophobicity of Dicationic Amphiphile-Stabilized Gold Nanoparticles on A549 Lung Cancer Cells

  2017cites this paper
• The Effect of Newly Synthesized Heterosteroids on miRNA34a, 98, and 214 Expression Levels in MCF-7 Breast Cancer Cells

  2017cites this paper
• Koelreuteria Formosana Extract Induces Growth Inhibition and Cell Death in Human Colon Carcinoma Cells via G2/M Arrest and LC3-II Activation-Dependent Autophagy

  2017cites this paper
• BRAF V600E-dependent role of autophagy in uveal melanoma

  2017cites this paper
• Auric Chloride Induced Micellization on Fractal Patterned Dicationic Amphiphiles and Stabilization of Gold Nanoparticles

  2017cites this paper
• Nigella sativa and its active constituent thymoquinone in oral health

  2016cites this paper
• Marine Mollusk‐Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance

  2016cites this paper
• Assessment of pathological response to neoadjuvant chemotherapy in locally advanced breast cancer using the Miller-Payne system and TUNEL.

  2016cites this paper
• In Vitro Growth Inhibitory Activities of Natural Products from Irciniid Sponges against Cancer Cells: A Comparative Study

  2016cites this paper
• Autophagy induction causes a synthetic lethal sensitization to ribonucleotide reductase inhibition in breast cancer cells

  2015cites this paper
• Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt‐based anti‐cancer drugs

  2015cites this paper
• Preliminary results from a prospective trial of preoperative combined BRAF and MEK-targeted therapy in advanced BRAF mutation-positive melanoma.

  2015cites this paper
• Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy.

  2015cites this paper
• Anticancer Potential and Mechanism of Action of Mango Ginger (Curcuma amada Roxb.) Supercritical CO2 Extract in Human Glioblastoma Cells

  2015cites this paper
• Thymoquinone Induces Cell Death in Human Squamous Carcinoma Cells via Caspase Activation-Dependent Apoptosis and LC3-II Activation-Dependent Autophagy

  2014cites this paper
• Chinese Medicines Induce Cell Death: The Molecular and Cellular Mechanisms for Cancer Therapy

  2014cites this paper
• Harnessing of Programmed Necrosis for Fighting against Cancers

  2014cites this paper
• Autophagy in Necrosis: A Force for Survival

  2014cites this paper
• Gold nanoparticles trigger apoptosis and necrosis in lung cancer cells with low intracellular glutathione

  2013cites this paper
• Inhibition of Mutant GNAQ Signaling in Uveal Melanoma Induces AMPK-Dependent Autophagic Cell Death

  2013cites this paper
• A Functional Yeast Survival Screen of Tumor-Derived cDNA Libraries Designed to Identify Anti-Apoptotic Mammalian Oncogenes

  2013cites this paper
• Endobiogeny: A Global Approach to Systems Biology (Part 2 of 2)

  2013cites this paper
• Finding chemo: the search for marine‐based pharmaceutical drugs active against cancer

  2013cites this paper
• Functional study of dextran-graft-poly((2-dimethyl amino)ethyl methacrylate) gene delivery vector for tumor therapy

  2013cites this paper
• Gallium-68: Chemistry and Radiolabeled Peptides Exploring Different Oncogenic Pathways

  2013cites this paper
• Activation of the intrinsic-apoptotic pathway in LNCaP prostate cancer cells by genistein- topotecan combination treatments

  2013cites this paper
• Breast cancer and possible mechanisms of therapy resistance

  2013cites this paper
• Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?

  2012cites this paper
• ryonia dioica aqueous extract induces apoptosis through mitochondrial intrinsic athway in BL 41 Burkitt ’ s lymphoma cells

  2012cites this paper
• Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group.

  2012cites this paper
• Bryonia dioica aqueous extract induces apoptosis through mitochondrial intrinsic pathway in BL41 Burkitt's lymphoma cells.

  2012cites this paper
• Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis

  2012cites this paper
• Cell Death and Cancer, Novel Therapeutic Strategies

  2012cites this paper
• Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy.

  2011cites this paper
• Simulation of Gene Regulatory Networks

  2011cites this paper
• 2. Introduction

  year unknowncites this paper